|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H,
Zou X and He J: Annual report on status of cancer in China, 2010.
Chin J Cancer Res. 26:48–58. 2014.PubMed/NCBI
|
|
3
|
Tavani A and La Vecchia C: Epidemiology of
renal-cell carcinoma. J Nephrol. 10:93–106. 1997.PubMed/NCBI
|
|
4
|
National Cancer Institute: Surveillance,
Epidemiology and End Results Program. SEER Stat Fact Sheets: Kidney
and Renal Pelvis Cancer. http://seer.cancer.gov/statfacts/html/kidrp.html.
Accessed December 12, 2015.
|
|
5
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: Contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
10
|
Carthew RW and Sontheimer EJ: Origins and
Mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fendler A, Stephan C, Yousef GM and Jung
K: MicroRNAs as regulators of signal transduction in urological
tumors. Clin Chem. 57:954–968. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rydzanicz M, Wrzesiński T, Bluyssen HA and
Wesoły J: Genomics and epigenomics of clear cell renal cell
carcinoma: Recent developments and potential applications. Cancer
Lett. 341:111–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu W, Zabirnyk O, Wang H, Shiao YH,
Nickerson ML, Khalil S, Anderson LM, Perantoni AO and Phang JM:
MiR-23b targets proline oxidase, a novel tumor suppressor protein
in renal cancer. Oncogene. 29:4914–4924. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferreira AF, Moura LG, Tojal I, Ambrósio
L, Pinto-Simões B, Hamerschlak N, Calin GA, Ivan C, Covas DT,
Kashima S and Castro FA: ApoptomiRs expression modulated by BCR-ABL
is linked to CML progression and imatinib resistance. Blood Cells
Mol Dis. 53:47–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yeung ML, Yasunaga J, Bennasser Y, Dusetti
N, Harris D, Ahmad N, Matsuoka M and Jeang KT: Roles for microRNAs,
miR-93 and miR-130b and tumor protein 53-induced nuclear protein 1
tumor suppressor in cell growth dysregulation by human T-cell
lymphotrophic virus 1. Cancer Res. 68:8976–8985. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sand M, Skrygan M, Sand D, Georgas D,
Gambichler T, Hahn SA, Altmeyer P and Bechara FG: Comparative
microarray analysis of microRNA expression profiles in primary
cutaneous malignant melanoma, cutaneous malignant melanoma
metastases and benign melanocytic nevi. Cell Tissue Res. 351:85–98.
2013. View Article : Google Scholar
|
|
17
|
Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I,
Wang C, Liu X and Zhou X: Down-regulation of the microRNA-99 family
members in head and neck squamous cell carcinoma. Oral Oncol.
48:686–691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dettmer MS, Perren A, Moch H, Komminoth P,
Nikiforov YE and Nikiforova MN: MicroRNA profile of poorly
differentiated thyroid carcinomas: New diagnostic and prognostic
insights. J Mol Endocrinol. 52:181–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leone V, Langella C, D'Angelo D, Mussnich
P, Wierinckx A, Terracciano L, Raverot G, Lachuer J, Rotondi S,
Jaffrain-Rea ML, et al: Mir-23b and miR-130b expression is
downregulated in pituitary adenomas. Mol Cell Endocrinol. 390:1–7.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Zhu MJ, Ren AM, Wu HF, Han WM, Tan
RY and Tu RQ: A ten-microRNA signature identified from a
genome-wide microRNA expression profiling in human epithelial
ovarian cancer. PLoS One. 9:e964722014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li BL, Lu C, Lu W, Yang TT, Qu J, Hong X
and Wan XP: MiR-130b is an EMT-related microRNA that targets DICER1
for aggression in endometrial cancer. Med Oncol. 30:4842013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colangelo T, Fucci A, Votino C, et al:
MicroRNA-130b promotes tumor development and is associated with
poor prognosis in colorectal cancer. Neoplasia. 15:1086–1099. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lai KW, Koh KX, Loh M, Tada K, Subramaniam
MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B, Ito Y and
Soong R; Singapore Gastric Cancer Consortium: MicroRNA-130b
regulates the tumour suppressor RUNX3 in gastric cancer. Eur J
Cancer. 46:1456–1463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao BS, Liu SG, Wang TY, Ji YH, Qi B, Tao
YP, Li HC and Wu XN: Screening of microRNA in patients with
esophageal cancer at same tumor node metastasis stage with
different prognoses. Asian Pac J Cancer Prev. 14:139–143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ratert N, Meyer HA, Jung M, Lioudmer P,
Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert
S and Jung K: MiRNA profiling identifies candidate mirnas for
bladder cancer diagnosis and clinical outcome. J Mol Diagn.
15:695–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Q, Zhao X, Zhang H, Yuan H, Zhu M,
Sun Q, Lai X, Wang Y, Huang J, Yan J and Yu J: MiR-130b suppresses
prostate cancer metastasis through down-regulation of MMP2. Mol
Carcinog. 23:222042014.
|
|
27
|
Zhao G, Zhang JG, Shi Y, Qin Q, Liu Y,
Wang B, Tian K, Deng SC, Li X, Zhu S, et al: MiR-130b is a
prognostic marker and inhibits cell proliferation and invasion in
pancreatic cancer through targeting STAT3. PLoS One. 8:e738032013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mitra R, Edmonds MD, Sun J, Zhao M, Yu H,
Eischen CM and Zhao Z: Reproducible combinatorial regulatory
networks elucidate novel oncogenic microRNAs in non-small cell lung
cancer. RNA. 20:1356–1368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wulfken LM, Moritz R, Ohlmann C,
Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel
G, von Ruecker A, Müller SC and Ellinger J: MicroRNAs in renal cell
carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS
One. 6:e257872011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM,
Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a
4-microRNA signature for clear cell renal cell carcinoma metastasis
and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
32
|
Maher ER: Genomics and epigenomics of
renal cell carcinoma. Semin Cancer Biol. 23:10–17. 2013. View Article : Google Scholar
|
|
33
|
Chow TF, Mankaruos M, Scorilas A, Youssef
Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, et
al: The miR-17-92 cluster is over expressed in and has an oncogenic
effect on renal cell carcinoma. J Urol. 183:743–751. 2010.
View Article : Google Scholar
|
|
34
|
Nakada C, Matsuura K, Tsukamoto Y,
Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida
T, Sato F, et al: Genome-wide microRNA expression profiling in
renal cell carcinoma: Significant down-regulation of miR-141 and
miR-200c. J Pathol. 216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sinha S, Dutta S, Datta K, Ghosh AK and
Mukhopadhyay D: Von Hippel-Lindau gene product modulates TIS11B
expression in renal cell carcinoma: Impact on vascular endothelial
growth factor expression in hypoxia. J Biol Chem. 284:32610–32618.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suresh S, McCallum L, Lu W, Lazar N,
Perbal B and Irvine AE: MicroRNAs 130a/b are regulated by BCR-ABL
and down-regulate expression of CCN3 in CML. J Cell Commun Signal.
5:183–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao Y, Miao G, Li Y, Isaji T, Gu J, Li J
and Qi R: MicroRNA-130b suppresses migration and invasion of
colorectal cancer cells through downregulation of integrin β1
[corrected]. PLoS One. 9:e879382014. View Article : Google Scholar
|
